CompletedNCT06564818
CYB003 compared with placebo as an add-on for depression
About this title
Read the official source — NCT06564818This study evaluated the safety and effectiveness of CYB003 for people with depression.
Medication studyAges 18–85United States
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of CYB003 for people with depression.
Who was this study for?
Listed age limits: 18 years to 85 years.
- Listed locations
- Phoenix and 44 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: December 17, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 223
- Sponsor
- Cybin IRL Limited
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 85 Years
- Official registry ID
- NCT06564818
- Official title
Show the full official title
A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedPhoenix · Tucson · Bellflower
35 more locations
- La Jolla
- Los Angeles
- Montclair
- Oceanside
- San Francisco
- San Juan Capistrano
- Denver
- Evergreen
- Hollywood
- Maitland
- Miami
- North Miami
- Orlando
- Tampa
- Atlanta
- Decatur
- Savannah
- Chicago
- Skokie
- New Orleans
- Rockville
- Boston
- Springfield
- Las Vegas
- Princeton
- New York
- The Bronx
- Monroe
- North Canton
- Philadelphia
- Memphis
- DeSota
- Houston
- Murray
- Orem
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of CYB003 for people with depression.
Who is behind this study?
The study sponsor is Cybin IRL Limited.
Did this study involve medication?
Yes. The study involved medication, including CYB003 and Placebo.
Who was this study for?
Listed age limits: 18 years to 85 years.
